{
    "clinical_study": {
        "@rank": "146389", 
        "arm_group": {
            "arm_group_label": "CLS001", 
            "arm_group_type": "Experimental", 
            "description": "CLS001"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to characterize the pharmacokinetics of once daily topical gel\n      and confirm that steady state conditions are reached under maximal use conditions following\n      3 weeks of daily applications."
        }, 
        "brief_title": "A 21 Day Pharmacokinetics Study in Papulopustular Rosacea", 
        "condition": "Papulopustular Rosacea", 
        "condition_browse": {
            "mesh_term": "Rosacea"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  A diagnosis of papulopustular rosacea\n\n          -  Grade 3 or 4 on the 5-point Investigator Global Assessment scale\n\n          -  Presence of telangiectasia\n\n        Exclusion Criteria:\n\n          -  steroid rosacea or subtype 3 (phymatous rosacea)\n\n          -  clinically significant abnormal findings that would interfere with study objective or\n             risk to safety for the subject.\n\n          -  nodular rosacea (lesions greater than 5mm with more than 2 modules)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02028286", 
            "org_study_id": "CLS001-CO-PR-002"
        }, 
        "intervention": {
            "arm_group_label": "CLS001", 
            "intervention_name": "CLS001", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Rosacea", 
        "lastchanged_date": "April 11, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Hackensack", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07601"
                    }, 
                    "name": "Frontage Clinical Services"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Derm Research"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase 1, Open Label, Multiple Center Study to Evaluate the Pharmacokinetics of Once-Daily CLS001 Topical Gel Under Maximal Use Conditions Administered for 21 Days in Subjects With Papulopustular Rosacea", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Plasma concentrations of CLS001 to determine pharmacokinetic parameters at visit 2, visit 3 and visit 5.", 
            "measure": "Plasma concentrations of CLS001 to determine pharmacokinetic parameters at visit 2, visit 3 and visit 5", 
            "safety_issue": "Yes", 
            "time_frame": "24 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02028286"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "incidence of adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "24 days"
        }, 
        "source": "Cutanea Life Sciences, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cutanea Life Sciences, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}